Hugh J. Herdon

Characterisation of the binding of [³H]‐SB‐674042, a novel nonpeptide antagonist, to the human orexin‐1 receptor

Christopher J. Langmead, Jeffrey C. Jerman, Stephen Brough et al. · British Journal of Pharmacology · 2004 · 136 citations · Full text

Molecular Pharmacology, Membrane Formats, Biochemistry +13

Characterization of a CNS penetrant, selective M₁muscarinic receptor agonist, 77‐LH‐28‐1

Christopher J. Langmead, Nigel Austin, Clive L. Branch et al. · British Journal of Pharmacology · 2008 · 131 citations · Full text

Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine and synthesis inhibition

Hugh J. Herdon, J Strupish, Stefan R. Nahorski · Brain Research · 1985 · 131 citations

Neurophysiology, Medicine, Endogenous Dopamine +10

Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors

Lauren T. May, Vimesh A. Avlani, Christopher J. Langmead et al. · Molecular Pharmacology · 2007 · 110 citations

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

Christopher J. Langmead, Victoria A. H. Fry, Ian T. Forbes et al. · Molecular Pharmacology · 2005 · 107 citations